Mechanisms of elevated serum creatinine in patients receiving vemurafenib for advanced melanoma.

被引：0
|
作者：
Hurabielle, Charlotte
Pillebout, Evangeline
Stehle, Thomas
Pages, Cecile
Roux, Jennifer
Schneider, Pierre
Chevret, Sylvie
Mourah, Samia
Basset-Seguin, Nicole
Chaffaut, Cendrine
Vidal-Petiot, Emmanuelle
Flamant, Martin
Lebbe, Celeste
机构：
[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France
[2] Hop St Louis, AP HP, Dept Nephrol, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France
[4] Univ Paris Diderot, Hop St Louis, AP HP, Biostat Dept,ECSTRA Team,Inserm,UMR 1153, Paris, France
[5] Hop St Louis, AP HP, Pharmacol & Genet Deparment, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20022
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma
    Hurabielle, Charlotte
    Pillebout, Evangeline
    Stehle, Thomas
    Pages, Cecile
    Roux, Jennifer
    Schneider, Pierre
    Chevret, Sylvie
    Chaffaut, Cendrine
    Boutten, Anne
    Mourah, Samia
    Basset-Seguin, Nicole
    Vidal-Petiot, Emmanuelle
    Lebbe, Celeste
    Flamant, Martin
    [J]. PLOS ONE, 2016, 11 (03):
  • [2] Vemurafenib in patients with metastatic malignant melanoma.
    Ocvirk, Janja
    Mesti, Tanja
    Boc, Marko
    Rebersek, Martina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Treatment with vemurafenib in patients with metastatic melanoma.
    Ocvirk, Janja
    Boc, Marko
    Mesti, Tanja
    Rebersek, Martina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.
    Shaikh, Saba
    Zang, Yan
    Hanmer, Janel
    Wang, Hong
    Lin, Yan
    Davar, Diwakar
    Zarour, Hassane M.
    Kirkwood, John M.
    Najjar, Yana G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] An Elevated Serum Creatinine in a Patient Receiving Palbociclib
    Bonilla, Marco A.
    Bashir, Khawaja A.
    Jhaveri, Kenar D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 579 - 580
  • [6] Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma
    Alonso-Castro, Leticia
    Rios-Buceta, Luis
    Vano-Galvan, Sergio
    Moreno, Carmen
    Soria-Rivas, Ainara
    Jaen, Pedro
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (01) : E28 - E29
  • [7] An imaging study of vemurafenib in patients with BRAFV600-mutated metastatic melanoma.
    Lastoria, Secondo
    Grimaldi, Antonio M.
    Aloj, Luigi
    Simeone, Ester
    Romano, Anna
    Caraco, Corradina
    Curvietto, Marcello
    Esposito, Assunta
    Caraco, Corrado
    Mozzillo, Nicola
    Torri, Valter
    Ascierto, Paolo Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Analysis of molecular mechanisms of response and resistance to vemurafenib (vem) in BRAFV600E melanoma.
    Sosman, Jeffrey Alan
    Pavlick, Anna C.
    Schuchter, Lynn Mara
    Lewis, Karl D.
    McArthur, Grant A.
    Cowey, Charles Lance
    Moschos, Stergios J.
    Flaherty, Keith T.
    Kim, Kevin B.
    Weber, Jeffrey
    Hersey, Peter
    Long, Georgina V.
    Lawrence, Donald P.
    Kockx, Mark
    Spleiss, Olivia
    Koehler, Astrid
    Bollag, Gideon
    Joe, Andrew K.
    Trunzer, Kerstin
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] The prognostic role of preoperative serum lactate dehydrogenase (LDH) in patients with resected advanced melanoma.
    Majithia, Neil
    Manana, Ana Velazquez
    Yan, Yiyi
    Kottschade, Lisa A.
    Dronca, Roxana Stefania
    Block, Matthew Stephen
    Nevala, Wendy Kay
    Markovic, Svetomir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy
    Shalaby, Alaa
    El-Saed, Aiman
    Voigt, Andrew
    Albany, Constantine
    Saba, Samir
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (05): : 575 - 579
12345